These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 30471512)

  • 1. Doxorubicin-induced chemoresistance in Duke's type B colon adenocarcinoma cell line is aggravated in the presence of TGF-β2 through non-apoptotic cell death.
    Sritharan S; Sivalingam N
    Clin Transl Oncol; 2024 Jul; 26(7):1630-1638. PubMed ID: 38308764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-proliferative activity of chitosan-coated oxypeucedanin nano-chitosomes (COPD-NCs) against human HT-29 colon cancer cells: in vitro study.
    Almohammed MAO; Meshkani S; Homayouni Tabrizi M; Sharbatiyan M; Nasiraei Haghighi H
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2133-2143. PubMed ID: 37787784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Viable and Heat-Inactivated
    Zhang Y; Cao T; Wang Y; Yang R; Han Y; Li S; Liu D; Yue Y; Cao Y; Li B; Wang S; Huo G
    Foods; 2024 Mar; 13(6):. PubMed ID: 38540948
    [No Abstract]   [Full Text] [Related]  

  • 4. Pomolic acid and its glucopyranose ester promote apoptosis through autophagy in HT-29 colon cancer cells.
    Liu LY; Yu TH; Liao TS; Xu P; Wang Y; Shi M; Li B
    World J Gastrointest Oncol; 2023 Oct; 15(10):1756-1770. PubMed ID: 37969414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium orthovanadate exhibits anti-angiogenic, antiapoptotic and blood glucose-lowering effect on colon cancer associated with diabetes.
    Patel K; Bora V; Patel B
    Cancer Chemother Pharmacol; 2024 Jan; 93(1):55-70. PubMed ID: 37755518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells.
    Fonseca P; Cui W; Struyf N; Tong L; Chaurasiya A; Casagrande F; Zhao H; Fernando D; Chen X; Tobin NP; Seashore-Ludlow B; Lundqvist A; Hartman J; Göndör A; Östling P; Holmgren L
    J Exp Clin Cancer Res; 2024 Apr; 43(1):107. PubMed ID: 38594748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic and Antiproliferative Effect of Purified Protein from Marine Catfish Tachysurus Dussumieri on Human Colon Cancer Cell Line.
    Raja K; Kallem P; Chinnasamy A
    Cell Biochem Biophys; 2024 Mar; 82(1):247-257. PubMed ID: 38183602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of Novel Tumour-Selective SEA Superantigen-Based Peptides with Improved Safety and Efficacy for Precision Cancer Immunotherapy.
    Bashraheel SS; Al-Sulaiti H; Goda SK
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel SPEA Superantigen Peptide Agonists and Peptide Agonist-TGFαL3 Conjugate. In Vitro Study of Their Growth-Inhibitory Effects for Targeted Cancer Immunotherapy.
    Bashraheel SS; Goda SK
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and In Vitro Evaluation of Antitumor Activity of TGFαL3-SEB as a Ligand-Targeted Superantigen.
    Yousefi F; Mousavi SF; Siadat SD; Aslani MM; Amani J; Rad HS; Fooladi AA
    Technol Cancer Res Treat; 2016 Apr; 15(2):215-26. PubMed ID: 25759426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tagging staphylococcal enterotoxin B (SEB) with TGFaL3 for breast cancer therapy.
    Yousefi F; Siadat SD; Saraji AA; Hesaraki S; Aslani MM; Mousavi SF; Imani Fooladi AA
    Tumour Biol; 2016 Apr; 37(4):5305-16. PubMed ID: 26561468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Design and Analysis of TGFαL3-SEB Fusion Protein as "a New Antitumor Agent" Candidate by Ligand-Targeted Superantigens Technique.
    Imani-Fooladi AA; Yousefi F; Mousavi SF; Amani J
    Iran J Cancer Prev; 2014; 7(3):152-64. PubMed ID: 25250167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARA-linker-TGFαL3: a novel chimera protein to target breast cancer cells.
    Ghadaksaz A; Imani Fooladi AA; Mahmoodzadeh Hosseini H; Nejad Satari T; Amin M
    Med Oncol; 2021 Jul; 38(8):96. PubMed ID: 34273028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth-inhibitory effects of TGFαL3-SEB chimeric protein on colon cancer cell line.
    Maleki F; Sadeghifard N; Hosseini HM; Bakhtiyari S; Goleij Z; Behzadi E; Sedighian H; Imani Fooladi AA
    Biomed Pharmacother; 2019 Feb; 110():190-196. PubMed ID: 30471512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFαL3-SEB fusion protein as an anticancer against ovarian cancer.
    Maleki F; Sadeghifard N; Sedighian H; Bakhtiyari S; Hosseini HM; Fooladi AAI
    Eur J Pharmacol; 2020 Mar; 870():172919. PubMed ID: 31935394
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.